Professional paper - Letter to the editor
Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis
Leukemia Research, 119 (2022); 106905. https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljic, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, Rajko

Cite this document

Lucijanić, M., Krečak, I., Sorić, E., Sabljic, A., Galušić, D., Holik, H. ... Kušec, R. (2022). Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research, 119.. doi: 10.1016/j.leukres.2022.106905

Lucijanić, Marko, et al. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research, vol. 119, 2022. https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, Marko, Ivan Krečak, Ena Sorić, Anica Sabljic, Davor Galušić, Hrvoje Holik, Vlatka Periša, Martina Morić Perić, Ivan Zekanović and Rajko Kušec. "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis." Leukemia Research 119 (2022). https://doi.org/10.1016/j.leukres.2022.106905

Lucijanić, M., et al. (2022) 'Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis', Leukemia Research, 119. doi: 10.1016/j.leukres.2022.106905

Lucijanić M, Krečak I, Sorić E, Sabljic A, Galušić D, Holik H, and sur.. Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis. Leukemia Research [Internet]. 2022 August [cited 2024 February 29];119. doi: 10.1016/j.leukres.2022.106905

M. Lucijanić, et al., "Patients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis", Leukemia Research, vol. 119, August 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:524953. [Accessed: 29 February 2024]

Please login to the repository to save this object to your list.